Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

Victor Chedid, Priya Vijayvargiya, Michael Camilleri

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	336-338
Number of pages	3
Journal	Clinical Gastroenterology and Hepatology
Volume	16
Issue number	3
DOIs	https://doi.org/10.1016/j.cgh.2017.11.025
State	Published - Mar 2018

ASJC Scopus subject areas

@article{1c1b2f0402fb442bb41c09f5cac0c62a,

title = "Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline",

author = "Victor Chedid and Priya Vijayvargiya and Michael Camilleri",

year = "2018",

month = mar,

doi = "10.1016/j.cgh.2017.11.025",

language = "English (US)",

volume = "16",

pages = "336--338",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

AU - Chedid, Victor

AU - Vijayvargiya, Priya

AU - Camilleri, Michael

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85040763184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040763184&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2017.11.025

DO - 10.1016/j.cgh.2017.11.025

M3 - Editorial

C2 - 29155353

AN - SCOPUS:85040763184

VL - 16

SP - 336

EP - 338

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 3

ER -